Berberine-loaded targeted nanoparticles as specific Helicobacter pylori eradication therapy: in vitro and in vivo study. - Wikidata - wikimedia - TriplyDB

Berberine-loaded targeted nanoparticles as specific Helicobacter pylori eradication therapy: in vitro and in vivo study.

Berberine-loaded targeted nanoparticles as specific Helicobacter pylori eradication therapy: in vitro and in vivo study.

http://www.wikidata.org/entity/Q35236166

about

Antibiotic treatment for Helicobacter pylori: Is the end coming?Berberine nanoparticles protects tubular epithelial cells from renal ischemia-reperfusion injury Delivery of berberine using chitosan/fucoidan-taurine conjugate nanoparticles for treatment of defective intestinal epithelial tight junction barrier.Effects of paeonol on anti-neuroinflammatory responses in microglial cells Dressing with epigallocatechin gallate nanoparticles for wound regeneration.Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.Development of genipin-crosslinked fucoidan/chitosan-N-arginine nanogels for preventing Helicobacter infection.Sustained release effects of berberine-loaded chitosan microspheres on in vitro chondrocyte culture.Enhanced antimicrobial effect of berberine in nanogel carriers with cationic surface functionality

P2860

Q26777623-8A1A11AC-A174-4C38-9201-9E505AD34CBC Q33648400-A2BED6AC-F709-4A2C-82C9-1463EB635550 Q35447220-1CFBC888-58AF-4E92-BACD-9E3AB877C5C9 Q35585752-4F043D44-D7A9-43FD-875F-53D47E3FC639 Q35809826-C15E3A22-3DE0-4855-AAA0-F814788736D6 Q38862706-482650E9-1010-41AD-8233-EAC5A6786090 Q40206079-5EE42606-850D-40A6-A145-1FAAB044C5ED Q50599085-8E5E247F-D98F-4327-808C-E8509DE74AD3 Q57377526-098784A1-C527-43EE-B1D2-372C873C07AF

P2860

Berberine-loaded targeted nanoparticles as specific Helicobacter pylori eradication therapy: in vitro and in vivo study.

http://www.wikidata.org/entity/Q35236166

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Berberine-loaded targeted nano ...... y: in vitro and in vivo study.

@ast

Berberine-loaded targeted nano ...... y: in vitro and in vivo study.

@en

type

label

Berberine-loaded targeted nano ...... y: in vitro and in vivo study.

@ast

Berberine-loaded targeted nano ...... y: in vitro and in vivo study.

@en

prefLabel

Berberine-loaded targeted nano ...... y: in vitro and in vivo study.

@ast

Berberine-loaded targeted nano ...... y: in vitro and in vivo study.

@en

P1433

Q35236166-04C070C3-DC3A-4BF4-B880-B02CC98A276A

P1476

Q35236166-4A44D4D1-0E16-49AB-B18C-608A3C8E8F9C

P2093

Q35236166-126E4516-040F-4BFC-A0AD-8001BF753F6E

Q35236166-1EA0B5EE-D23E-415B-B66B-AD28F5AE4D5D

Q35236166-34C8E47A-A45A-4DAC-A90A-C5DB0C4FA77C

Q35236166-3DBFEB3C-9110-4CCC-B61D-E36D8D744DA5

Q35236166-4EBFEBC9-408A-46F7-9958-5E05BC2C03DB

Q35236166-92C7FD68-7899-44AF-91D3-BD6307465F74

Q35236166-C7903365-133E-45C8-966B-071D57A928B4

P2860

Q35236166-05DE2289-CA8C-4CFE-8F1F-94764287BFC5

Q35236166-0600D1C0-1AC9-437C-96FC-9179521C30CA

Q35236166-06A94152-419F-4C8F-BFCC-A0670590D6FE

Q35236166-06F8FF0A-E1FD-4118-B279-3BDE6FEB4B30

Q35236166-0B562F29-3193-4119-9A15-2A71756E1304

Q35236166-0E657B97-5425-456C-9349-55F6D7C0ECF9

Q35236166-1F111F8B-BA56-48ED-9025-51126093EBD6

Q35236166-249A0567-74A2-420B-BE5E-0F8F309B64E9

Q35236166-26E76E04-FCCC-467D-8A3E-7CD35759A595

Q35236166-2823EE3E-0230-4BE2-9A5D-CF8C4F885E95

P304

Q35236166-728B9046-867D-4640-A874-174643862BB3

P31

Q35236166-22F2FBF6-D016-47AC-A145-07B53726F0AB

P356

Q35236166-E062FC5B-1BF7-48DA-9A31-1438225B078A

P433

Q35236166-080354E1-BA07-474E-A4A6-2BBCCFA75730

P478

Q35236166-366AA511-BEC0-4775-8129-D0944B0A7D72

P577

Q35236166-D1948B39-9EFF-4441-B300-B822D8621424

P698

Q35236166-2112AB0C-2835-4BBE-B06E-D277C87A518C

P921

Q35236166-5D6A494F-E914-4229-AD49-0DCD7CD0F320

P356

P1433

P1476

Berberine-loaded targeted nano ...... y: in vitro and in vivo study.

@en

P2093

Chiung-Hung Chang

http://www.w3.org/2001/XMLSchema#string

Chun-Chia Chung

http://www.w3.org/2001/XMLSchema#string

Jui-Hsiang Lin

http://www.w3.org/2001/XMLSchema#string

Shen-Chieh Chou

http://www.w3.org/2001/XMLSchema#string

Shu-Jen Chang

http://www.w3.org/2001/XMLSchema#string

Yu-Hsin Lin

http://www.w3.org/2001/XMLSchema#string

Yueh-Sheng Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Structural basis for oligosaccharide-mediated adhesion of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients

Structural basis of carbohydrate recognition by the lectin LecB from Pseudomonas aeruginosa

Gastric mucosal cell model for estimating relative gastrointestinal toxicity of non-steroidal anti-inflammatory drugs

Fabrication of {198Au0} radioactive composite nanodevices and their use for nanobrachytherapy.

New insights on trehalose: a multifunctional molecule.

Fucose: biosynthesis and biological function in mammals.

Helicobacter pylori and gastric cancer: factors that modulate disease risk.

Helicobacter pylori activates myosin light-chain kinase to disrupt claudin-4 and claudin-5 and increase epithelial permeability.

Drug transfer through mucus.

Chitosan and its derivatives as intestinal absorption enhancers.

P304

57-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/NNM.14.76

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25177920

http://www.w3.org/2001/XMLSchema#string

P921

Helicobacter pylori